Wall Street Bullish on AtaiBeckley (ATAI), Here's Why
AtaiBeckley Inc. (NASDAQ:ATAI) is one of the Best Penny Stocks That Will Skyrocket. Wall Street is bullish on AtaiBeckley Inc. (NASDAQ:ATAI) with analysts’ 12-month median price target reflecting more than 202% upside. Recently, on January 28, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on the stock with a $15 price target. Earlier, Eddie Hickman from Guggenheim also initiated AtaiBeckley Inc. (NASDAQ:ATAI) with a Buy rating and a $11 price target.
Hickman from Guggenheim noted that the company is a differentiated leader in next-generation psychiatry. The analyst also highlighted the recent merger with Beckley Psytech, which gives the company full ownership of BPL-003. BPL-003 is a lead asset that treats treatment-resistant depression and has shown compelling results in Phase IIIb efficacy and durability. The analyst believes that BPL-003 is strongly positioned for rapid clinical adoption and commercial scaling.
Phase 2 trials of BPL-003 showed sustained MADRS score reductions, with 63% responder rates and 48% remission rates after a second dose. Moreover, Phase 3 trials are planned for Q2 2026 following FDA Breakthrough Therapy Designation.
AtaiBeckley Inc. (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company that researches, develops, and commercializes mental health treatments in the US, Germany, and Canada.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Target Q3 revenue and profit both exceed expectations, same-store sales grow by 5.6%, annual guidance raised for the third time this year | Earnings Report Insights
Target's revenue for the third fiscal quarter reached $27.1 billion, up 7.1% year-over-year, with comparable store sales increasing by 5.6%. Adjusted earnings per share stood at $2.65, all surpassing analysts' expectations. This quarter's results include a $0.50 per share benefit from tariff refunds; even excluding this, adjusted EPS still grew 21% year-over-year. Target's stock price fell in pre-market trading but subsequently reversed, soaring over 7.7% intraday, with a cumulative increase of about 78% so far this year.
Metals Crash! Intraday Copper Futures Drop Nearly 6%, Silver Futures Fall Over 5% as Rate Hike Expectations and Cooling AI Trading Take Their Toll
On Wednesday, London copper closed at a seven-month low. The cooling of AI trading has become a key trigger for the plunge in copper futures. Previously, long-time bull Druckenmiller stated on Tuesday that he has turned bearish on copper, and industry insiders say current demand is closer to a recessionary environment. Fed’s Waller raised the possibility of a 50 basis point rate hike in December, intensifying rate hike expectations, strengthening the US dollar, and pushing gold to a 14-month low. Gold futures dropped more than 3% intraday. Beyond the US dollar and interest rates, capital outflows are amplifying the decline in metals.

K33 Research calls Bitcoin below $70,000 a ‘gift’ after 14% weekly drop

